Document is current
Any future updates will be listed below
-
Authors
Bjerre, Frederik Adam
Nielsen, Jakob Vennike
Burton, Mark
Dhumale, Pratibha
Jørgensen, Mads Gustaf
Hansen, Sabrina Toft
Lund, Lars
Thomassen, Mads
Sørensen, Jens Ahm
Andersen, Ditte Caroline
Jensen, Charlotte Harken https://orcid.org/0000-0001-9683-8761
-
Funding
Funding for this research was provided by:
Innovationsfonden (7051-00001A)
Novo Nordisk Fonden (21OC0071847, 19OC0055353)
Odense Universitetshospital
Region Syddanmark
Klinisk Institut, Syddansk Universitet
- License Information
-
More Information
Article History
Received: 22 January 2025
Accepted: 14 February 2025
First Online: 5 March 2025
Declarations
:
: The pRP-ED-trial (entitled “Can fat derived stem cells (SVF) be used in the treatment of erectile dysfunction after prostatectomy—a randomized, placebo-controlled, double-blind clinical trial”) was approved on January 29th, 2018 by the Danish National Ethics Committee (no. 2017070103) and the BCRL-trial (entitled “Treatment of breast cancer-related lymphedema with stem cells and fat grafting”) by The Regional Committees on Health Research Ethics for Southern Denmark on December 7th, 2018 (no. S-20180117). Both studies were performed in accordance with the Declaration of Helsinki and ICH-GCP guidelines and all patients gave written informed consent before participation.
: The informed consent in both trials included a section regarding publication of study data and was signed by all patients.
: The authors declare no competing interests.
: The authors declare that they have not used Artificial Intelligence in this study.
